Latest Insider Transactions at Global Blood Therapeutics, Inc. (GBT)
This section provides a real-time view of insider transactions for Global Blood Therapeutics, Inc. (GBT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Global Blood Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Global Blood Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
342
+1.72%
|
$12,312
$36.21 P/Share
|
|
Feb 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,178
-10.98%
|
$57,722
$49.49 P/Share
|
|
Feb 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,020
+21.96%
|
-
|
|
Feb 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
267
+3.35%
|
$10,947
$41.17 P/Share
|
|
Feb 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,865
-27.58%
|
$287,385
$49.49 P/Share
|
|
Feb 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,083
+36.23%
|
-
|
|
Feb 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,458
-8.34%
|
$120,442
$49.49 P/Share
|
|
Feb 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,770
+18.67%
|
-
|
|
Feb 01
2021
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,646
-2.56%
|
$227,654
$49.49 P/Share
|
|
Feb 01
2021
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,083
+6.72%
|
-
|
|
Feb 01
2021
|
Eric Fink Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
947
-28.34%
|
$46,403
$49.49 P/Share
|
|
Feb 01
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,020
+47.47%
|
-
|
|
Feb 01
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
322
+50.0%
|
$13,524
$42.6 P/Share
|
|
Feb 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,399
-15.03%
|
$166,551
$49.49 P/Share
|
|
Feb 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,395
+29.34%
|
-
|
|
Feb 01
2021
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,893
-2.26%
|
$876,757
$49.49 P/Share
|
|
Feb 01
2021
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,018
+5.04%
|
-
|
|
Oct 05
2020
|
Eric Fink Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,532
-100.0%
|
$271,920
$60.0 P/Share
|
|
Oct 01
2020
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,170
-8.72%
|
$123,690
$57.96 P/Share
|
|
Oct 01
2020
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+14.95%
|
-
|
|
Dec 19
2017
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
175,000
+3.46%
|
$6,650,000
$38.0 P/Share
|